600
Participants
Start Date
October 7, 2021
Primary Completion Date
December 15, 2024
Study Completion Date
December 15, 2024
Mucosta®SR Tablets 150mg(Rebamipide)
adult patients with gastric mucosal lesions (erosion, bleeding, redness, and edema) of acute gastritis or acute exacerbation of chronic gastritis prescribed with Mucosta®SR Tab. according to the medical considerations of the investigator.
RECRUITING
Soon Chun Hyang University Hospital Seoul, Seoul
Lead Sponsor
Korea Otsuka Pharmaceutical Co., Ltd.
INDUSTRY